Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
Go back to Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update| GALECTIN (NASDAQ: GALT) | Delayed: 4.05 -0.09 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.14 | 52 Week High | $3.05 | |||
| Open | $4.13 | 52 Week Low | $0.49 | |||
| Day High | $4.34 | P/E | N/A | |||
| Day Low | $4.04 | EPS | $-1.32 | |||
| Volume | 515,590 | |||||

